Cambridge, Massachusetts-based clinical biotech firm City Therapeutics has set terms for its upcoming initial public offering on the NASDAQ under…
As Capitol Hill navigates a dense legislative calendar and mounting economic pressures, lawmakers continue to weigh in on critical fiscal…
Sign in to your account